Say Hello!
Don’t be shy.

   

Investment Tag

BioCity Nottingham based Sygnature Discovery, the leading provider of integrated drug discovery services, has received a significant investment from Five Arrows Principal Investments, the European corporate private equity arm of Rothschild & Co. Financial details have not been disclosed. Sygnature is a world-class provider of outsourced...

BioCity investee, Rinri Therapeutics, a biotechnology company developing a novel stem cell therapy to restore hearing, today announces that it has raised a total of £10 million from existing investors Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures and BioCity alongside the UK Government Future Fund....

Image: Professors Alessio Ciulli and Sir Mike Ferguson Drugs development firm Amphista Therapeutics has unveiled a £38 million investment that will enhance its work to develop treatments for a range of diseases. The company is a spinout from Professor Alessio Ciulli’s labs at the University of Dundee’s School...

Glasgow-based IbisVision is ramping up the launch of its remote vision testing technology by bringing on additional staff in the UK and the US, its two main markets. Currently employing 10 people, the company has added two client-facing staff in the US where one of its...